Dr Misba Beerahee

Misba Beerahee PhD has over four decades of pharmaceutical development experience as a clinical pharmacologist working across a wide range of therapeutic areas, including immunology, immuno-oncology, respiratory and anti-infectives. He has extensively applied quantitative clinical pharmacology principles to both Drug Discovery and Development of small molecules and biologicals (including bispecifics and ADCs) providing ‘hands-on’ pharmacometrics support, including model-based clinical trial simulations. Misba has a proven track record in integrating Model-Informed Drug Development (MIDD) into early and late phases of drug development, facilitating the optimisation of clinical drug development strategies. He has vast experience in the regulatory submission space, having had key accountability for the clinical pharmacology aspects of ten successful primary FDA NDA drug approvals.

Interested in speaking with a consultant?

We’ll arrange a brief consultation for you with a specialist in our team.